Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine as an Adjunctive Therapy for Major Depression - A Randomised Controlled Trial: [KARMA-Dep (2)]


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04939649

Organisation Name: University of Dublin, Trinity College

Overal Status: Recruiting

Start Date: September 13, 2021

Last Update: September 16, 2021

Lead Sponsor: University of Dublin, Trinity College

Brief Summary: Pragmatic, randomised, controlled, parallel-group, superiority trial of ketamine vs. midazolam as an adjunctive therapy for depression. The main purpose of the trial is to assess the mood-rating score difference between ketamine and midazolam from before the first infusion to 24 hours after the final infusion, supplemented by a 95% confidence interval. There will also be a 24-week follow-up after the final infusion session.

Conditions:
  • Major Depressive Episode
  • Unipolar Depression
  • Bipolar Depression


Total execution time in seconds: 0.44499897956848